Benign Hyperplastic Nodule in the Peripheral Zone of the Prostate Mimicking Prostate Cancer on 18 F-PSMA-1007 PET/CT.

Clin Nucl MedJul 8, 2026 (epub)

Xiaojun Man, Changming Dong, Aisheng Dong et al.

✦ AI-curated · Sources linked

Case in brief

A patient presented with a large benign hyperplastic nodule located in the peripheral zone of the prostate, which is an atypical site for benign prostatic hyperplasia. Imaging studies, including MRI and 18 F-PSMA-1007 PET/CT, revealed a well-defined mass with heterogeneous signal intensity and increased uptake of 18 F-PSMA-1007, mimicking prostate cancer. The nodule was ultimately diagnosed as benign.

What made this case unusual

The benign hyperplastic nodule's location in the peripheral zone is rare, as benign prostatic hyperplasia typically occurs in the para-urethral transition zone.

Diagnostic / clinical pearl

Clinicians should be aware that benign prostatic hyperplastic nodules can occur in the peripheral zone and may exhibit increased PSMA uptake, potentially mimicking prostate cancer.

Why it matters

This case highlights the importance of considering benign conditions in differential diagnoses when interpreting PSMA PET/CT findings in the prostate.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Urology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.